-
1.COMPOUNDS FOR TREATING DISORDERS WHERE A DECREASED LEVEL OF PLASMA FFA IS DESIRED 审中-公开
Title translation: 用于治疗疾病的化合物,其中需要降低血浆FFA水平公开(公告)号:WO0187843A8
公开(公告)日:2002-02-07
申请号:PCT/DK0100341
申请日:2001-05-15
Applicant: NOVO NORDISK AS , BELTRANDELRIO HECTOR , JACOBSEN POUL , CORNELIS DE JONG JOHANNES
Inventor: BELTRANDELRIO HECTOR , JACOBSEN POUL , CORNELIS DE JONG JOHANNES
IPC: A61P3/00 , A61P3/10 , A61P43/00 , C07D217/08 , C07D217/00 , A61K31/4453 , A61K31/472 , A61K31/5375 , C07D295/32
CPC classification number: C07D217/08
Abstract: The present invention relates to novel compounds of general formula (I), wherein A is a nitrogen containing ring systen attached through the nitrogen atom, compositions containing them, and their use for treating medical disorders where a decreased level of plasma free fatty acids (FFA) is desired.
Abstract translation: 本发明涉及通式(I)的新化合物,其中A是通过氮原子连接的含氮环系统,含有它们的组合物及其用于治疗其中血浆游离脂肪酸水平降低(FFA) )。
-
2.COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE 审中-公开
Title translation: 化合物及其用于降低敏感性脂质体活性的用途公开(公告)号:WO03051841A2
公开(公告)日:2003-06-26
申请号:PCT/DK0200852
申请日:2002-12-13
Applicant: NOVO NORDISK AS
Inventor: EBDRUP SOEREN , CORNELIS DE JONG JOHANNES , JACOBSEN POUL , HANSEN HOLGER CLAUS , VEDSOE PER
IPC: C07D249/08 , A61K31/16 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/343 , A61K31/352 , A61K31/37 , A61K31/381 , A61K31/40 , A61K31/401 , A61K31/4015 , A61K31/4035 , A61K31/4045 , A61K31/407 , A61K31/41 , A61K31/415 , A61K31/4155 , A61K31/4164 , A61K31/4184 , A61K31/4192 , A61K31/4196 , A61K31/423 , A61K31/426 , A61K31/428 , A61K31/437 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4439 , A61K31/444 , A61K31/445 , A61K31/451 , A61K31/4545 , A61K31/455 , A61K31/465 , A61K31/47 , A61K31/4709 , A61K31/472 , A61K31/4725 , A61K31/473 , A61K31/495 , A61K31/496 , A61K31/498 , A61K31/4995 , A61K31/50 , A61K31/505 , A61K31/5375 , A61K31/5377 , A61K31/541 , A61K31/55 , A61K31/551 , A61K31/63 , A61K45/00 , A61P1/04 , A61P1/18 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/50 , A61P9/04 , A61P9/06 , A61P9/10 , A61P9/12 , A61P17/06 , A61P21/04 , A61P25/16 , A61P25/22 , A61P25/24 , A61P25/28 , A61P27/02 , A61P29/00 , A61P31/04 , A61P31/18 , A61P35/00 , A61P43/00 , C07C39/367 , C07C233/25 , C07C233/26 , C07C233/60 , C07C269/00 , C07C271/58 , C07C275/34 , C07C303/34 , C07C303/38 , C07C307/06 , C07C311/04 , C07C311/17 , C07C311/21 , C07C311/29 , C07C311/40 , C07C317/22 , C07C323/20 , C07D207/325 , C07D207/36 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/32 , C07D209/48 , C07D211/40 , C07D211/88 , C07D213/61 , C07D213/63 , C07D213/64 , C07D213/643 , C07D213/65 , C07D213/68 , C07D213/69 , C07D213/70 , C07D213/74 , C07D213/75 , C07D213/82 , C07D213/84 , C07D215/14 , C07D215/20 , C07D215/22 , C07D217/06 , C07D217/24 , C07D221/14 , C07D231/12 , C07D231/14 , C07D231/16 , C07D231/18 , C07D233/54 , C07D233/60 , C07D233/70 , C07D233/84 , C07D235/18 , C07D235/26 , C07D237/14 , C07D239/22 , C07D239/34 , C07D239/38 , C07D241/18 , C07D241/44 , C07D249/04 , C07D249/12 , C07D249/18 , C07D253/04 , C07D257/04 , C07D261/12 , C07D261/20 , C07D263/52 , C07D277/20 , C07D277/24 , C07D277/34 , C07D277/68 , C07D285/00 , C07D285/01 , C07D295/18 , C07D295/20 , C07D295/205 , C07D295/26 , C07D307/16 , C07D307/28 , C07D307/52 , C07D307/89 , C07D311/16 , C07D311/18 , C07D333/16 , C07D333/32 , C07D333/34 , C07D333/40 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D471/06 , C07D487/08 , C07D487/18 , C07D491/10 , C07D513/04 , C07D521/00 , C07D213/00
CPC classification number: C07D207/404 , C07C39/367 , C07C233/25 , C07C233/26 , C07C233/60 , C07C307/06 , C07C311/04 , C07C311/17 , C07C311/21 , C07C311/29 , C07C311/40 , C07C317/22 , C07C323/20 , C07C2601/14 , C07D209/08 , C07D209/32 , C07D209/48 , C07D211/88 , C07D213/61 , C07D213/63 , C07D213/64 , C07D213/643 , C07D213/68 , C07D213/69 , C07D213/70 , C07D213/74 , C07D213/75 , C07D213/84 , C07D215/20 , C07D215/22 , C07D217/24 , C07D231/12 , C07D231/16 , C07D233/54 , C07D233/56 , C07D235/18 , C07D235/26 , C07D237/14 , C07D239/22 , C07D241/18 , C07D241/44 , C07D249/04 , C07D249/08 , C07D249/18 , C07D253/04 , C07D257/04 , C07D261/12 , C07D263/52 , C07D277/24 , C07D277/68 , C07D285/01 , C07D295/205 , C07D295/26 , C07D307/16 , C07D307/52 , C07D307/89 , C07D311/16 , C07D311/18 , C07D333/16 , C07D333/32 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D471/06 , C07D491/10
Abstract: Use of compounds to inhibit hormone-sensitive lipase, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.
Abstract translation: 使用化合物抑制激素敏感性脂肪酶,包含化合物的药物组合物,使用这些化合物和组合物的治疗方法以及新化合物。 本发明化合物是激素敏感性脂肪酶的抑制剂,并且可用于治疗和/或预防需要激素敏感性脂肪酶活性降低的医学病症。
-
3.PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES 审中-公开
Title translation: 吡咯并[2,1-cd]吲哚衍生物用于预防或治疗雌激素相关疾病或综合征公开(公告)号:WO9855483A9
公开(公告)日:2000-02-03
申请号:PCT/DK9800232
申请日:1998-06-02
Applicant: NOVO NORDISK AS
Inventor: JOERGENSEN ANKER STEEN , JACOBSEN POUL , CHRISTIANSEN LISE BROWN , BURY PAUL STANLEY , KANSTRUP ANDERS
IPC: C07D491/22 , A61K31/437 , A61P3/04 , A61P3/10 , A61P5/00 , A61P9/00 , A61P13/00 , A61P13/08 , A61P15/00 , A61P15/06 , A61P15/12 , A61P17/10 , A61P19/08 , A61P19/10 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07D471/04 , C07D471/16 , A61K31/44
CPC classification number: C07D471/16
Abstract: The present invention relates to therapeutically active compounds of formula (I), a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.
Abstract translation: 本发明涉及式(I)的治疗活性化合物,其制备方法和包含该化合物的药物组合物。 新型化合物可用于预防或治疗雌激素相关疾病或综合征。
-
-